LINFU®

DIAGNOSTIC_TEST2 trials

Sponsors

Adenocyte, LLC

Conditions

IPMN, PancreaticPancreas CancerPancreatic CancerPancreatic CystPancreatic Ductal AdenocarcinomaPancreatic Dysplasia

Unknown Phase

The LINFU® U.S. Registry for the in the General Population Without Risk Factors

Not yet recruitingNCT06276803

Adenocyte, LLCPancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatic Dysplasia

Start: 2024-09-15End: 2034-12-15Target: 500Updated: 2024-07-31

The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas)

Enrolling by invitationNCT06276764

Adenocyte, LLCIPMN, Pancreatic, Pancreas Cancer, Pancreatic Cyst

Start: 2024-10-15End: 2034-12-01Target: 500Updated: 2026-08-06